GlassScriptPhysician profile
Matthew L Olson
NPI 1821657198
$1,496.99
in general payments reported to CMS, 2019-2025
20 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.96 · 2020: $75.86 · 2021: $285 · 2022: $208 · 2023: $193 · 2024: $370 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.96 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $252.23 | 2021-2025 | Rocklatan, Tryptyr, Clareon |
| Tarsus Pharmaceuticals, INC. | $213.84 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $196.92 | 2022-2025 | Tyrvaya, Ryzumvi |
| Coopervision INC. | $136.99 | 2019-2025 | Misight Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Aerie Pharmaceuticals, INC. | $96.32 | 2020-2021 | |
| Abbvie INC. | $76.62 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $76.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $68.22 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $62.73 | 2020-2025 | |
| Bausch & Lomb Americas INC. | $55.55 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Horizon Therapeutics Plc | $47.22 | 2022 | |
| Dompe US, INC. | $47.04 | 2024 | Oxervate |
| Rxsight INC | $39.25 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Allergan, INC. | $30.85 | 2021 | |
| Abb Con-Cise Optical Group LLC | $24.18 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synergeyes, INC. | $19.69 | 2021 | |
| Thea Pharma INC. | $18.96 | 2024 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.84 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $11.66 | 2020 | |
| Tearlab Corp | $10.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.